Brought to you by 
Anacor files for IPO; withdrawn 16 months later
30 Dec 2008
Executive Summary
Anacor Pharmaceuticals (small molecules to treat fungal, bacterial, and inflammatory diseases) has filed for its initial public offering in which it hopes to raise up to $57.5mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Anacor files for IPO; withdrawn 16 months later
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice